XILOIAL

XILOIAL ZERO OPHTHALMIC SOLUTION 10 ML

XILOIAL ZERO OPHTHALMIC SOLUTION 10 ML

Skip to product information
1 of 2
  • Secure payment
  • Discreet and sanitized package
  • Fast and safe shipping

Description

Descriptive sheet

XILOIAL ZERO

CE medical device, class IIb. Sterile ophthalmic solution with 0.2% Hyaluronic Acid and 0.2% TS-Polysaccharide. The high molecular weight hyaluronic acid present in XILOIAL ZERO creates mucomimetic solutions with high lubricating properties; the viscosity of this solution is such as to allow for a high hydrating effect and stabilization of the tear film. TS-Polysaccharide is a plant-based substance extracted from the seeds of the tamarind plant ( Tamarindus Indica ) useful for protecting the corneal and conjunctival surface. TS-Polysaccharide forms a protective film on the ocular surface that can help restore the normal physiological balance of the tear film and the ocular surface.
Sterile, preservative-free ophthalmic solution indicated for the treatment of dry eye. XILOIAL ZERO is recommended for immediate, rapid relief and long-lasting protection of the corneal and conjunctival surface from burning, redness, and irritation caused by physical environmental factors (wind, prolonged exposure to sunlight, cigarette smoke, dry air), visual stress (intense eye strain, computer screens), or mechanical factors (contact lenses, eye surgery). The product can be used with contact lenses, given the absence of preservatives in the formulation.

How to use
Instill 1 or 2 drops of XILOIAL ZERO into the eye, applying light pressure to the bottle. This can be repeated several times a day, as needed.

Warnings
The product is for external ophthalmic use only. After administration, temporary blurred vision may occur, which disappears within a few minutes. It is advisable to wait for the blurred vision to disappear before undertaking any activity requiring clear vision (driving, operating machinery, etc.). Do not use Xiloial ZERO if the bottle is damaged. Avoid touching the eye with the tip of the bottle. Do not dispense more than 30 drops at a time. Do not use if you have a known incompatibility with any component of the preparation. Allow 10-15 minutes between instilling Xiloial ZERO and any other medications for external ophthalmic use. Do not use the product after the expiration date indicated on the package. Keep out of the reach and sight of children. Do not ingest.

Conservation
Store below 25°C. Use the bottle within 90 days of first opening. Do not dispose of the bottle in the environment after use.

Components
Hyaluronic acid; TS-polysaccharide; mannitol; sodium phosphate monobasic monohydrate; sodium phosphate dibasic dodecahydrate; water for injections.

Format
10 ml preservative-free multi-dose bottle.

Code 373

XILOIAL

XILOIAL ZERO OPHTHALMIC SOLUTION 10 ML

XILOIAL ZERO OPHTHALMIC SOLUTION 10 ML

MINSAN code: 933868263
Previous price: €21,70
Regular price €21,70
Regular price €0,00 Sale price €21,70
-% Sold out
Tax included. Shipping calculated at checkout.
View full details

Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.